We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological ... read more Featured Products: More products

Download Mobile App




Early Gene Changes Identified That Precede Blood Cancer

By LabMedica International staff writers
Posted on 15 Dec 2014
Print article
Illumina\'s HiSeq 2000 sequencing platform
The HiSeq 2000 sequencing platform (Photo courtesy of Illumina)
DNA samples have been used to uncover early, precancerous genetic changes in the blood that are linked to increased chances of developing blood cancers such as leukemia, lymphoma or myelodysplastic syndrome.

The development of disease often involves dynamic processes that begin years or decades before the clinical onset and in many cases the process of pathogenesis goes undetected until after the patient has symptoms and presents with clinically apparent disease.

A large team of scientists led by those at Harvard Medical School (Boston, MA, USA) obtained blood samples for DNA sequencing from 12,380 Swedish persons whose mean age at time of sample collection was 55 years. The cohort included 6,245 controls, 4,970 persons with schizophrenia, and 1,165 persons with bipolar disorder. DNA was extracted directly from peripheral venous blood samples.

The initial sequencing was carried out using the genome analyzer GAII (Illumina; San Diego, CA, USA) instruments and the remaining specimens were sequenced using Illumina’s HiSeq 2000 and HiSeq 2500 instruments, with pair ended sequencing reads of 76 base pairs across all specimens. Sequencing was performed at the Broad Institute (Cambridge, MA, USA) and Harvard across the period of time from 2010 to 2013.

The team found that a subset, some, but not all, of mutations known to feature in blood cancers were present in individuals who were 10 times more likely to develop blood cancer later in life, compared with individuals who did not have these mutations. This cluster of pre-cancerous mutations, which was easily detected by DNA sequencing, is rarely found in the blood of people under the age of 40. It becomes more common with age and appears in more than 10% of people over the age of 70. Most of the mutations occurred in just three genes: DNA (cytosine-5)-methyltransferase 3A (DNMT3A), tet methylcytosine dioxygenase 2 (TET2) and, additional sex combs like transcriptional regulator 1 (ASXL1).

Steven A. McCarroll, PhD, an assistant professor of genetics and a senior author of the study said, “The results demonstrate a way to identify high-risk cohorts, people who are at much higher than average risk of progressing to cancer, which could be a population for clinical trials of future prevention strategies. The abundance of these mutated cells could also serve as a biomarker to test the effects of potential prevention therapies in clinical trials.” The study was published on November 26, 2014, in the New England Journal of Medicine (NEJM).

Related Links:

Harvard Medical School
Illumina 
Broad Institute 


Gold Member
Hematology Analyzer
Swelab Lumi
Automated Blood Typing System
IH-500 NEXT
New
Quantitative Immunoassay Analyzer
AS050
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: LMU’s Professor Frederick Klauschen developed the novel approach that can improve diagnostic accuracy (Photo courtesy of LMU Munich)

AI Tool Uses Imaging Data to Detect Less Frequent GI Diseases

Artificial intelligence (AI) is already being utilized in various medical fields, demonstrating significant potential in aiding doctors in diagnosing diseases through imaging data. However, training AI... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.